Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Response”

221 trials

Showing 20 of 221 results

Large-scale testing (Phase 3)Study completedNCT00036608
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Not applicableStudy completedNCT00887887
What this trial is testing

The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery

Who this might be right for
Liver Disease
Maastricht University Medical Center 100
Not applicableUnknownNCT02921139
What this trial is testing

Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)

Who this might be right for
Hepatocellular Carcinoma(HCC)
Dalin Tzu Chi General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00394472
What this trial is testing

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
AstraZeneca 244
Not applicableEnded earlyNCT01073436
What this trial is testing

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 7
Not applicableStudy completedNCT01147185
What this trial is testing

Effectiveness of Automated Locomotor Training in Patients With Acute Incomplete Spinal Cord Injury: A Multicenter Trial

Who this might be right for
Spinal Cord Injuries
University of Zurich 21
Testing effectiveness (Phase 2)Study completedNCT01234558
What this trial is testing

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 115
Post-approval studies (Phase 4)Study completedNCT04330040
What this trial is testing

Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerBreast Cancer
AstraZeneca 202
Not applicableUnknownNCT00638469
What this trial is testing

UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis

Who this might be right for
Psoriasis
Medical University of Graz 10
Early research (Phase 1)Ended earlyNCT01068145
What this trial is testing

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Merck Sharp & Dohme LLC 18
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Study completedNCT00791999
What this trial is testing

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Otsuka Pharmaceutical Co., Ltd. 316
Testing effectiveness (Phase 2)Study completedNCT01043185
What this trial is testing

Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 27
Large-scale testing (Phase 3)Study completedNCT00152386
What this trial is testing

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 950
Not applicableNot Yet RecruitingNCT07664137
What this trial is testing

Effect of Central Sensitization on Response to Physical Therapy in Patients With Partial Supraspinatus Tear

Who this might be right for
Rotator Cuff Tears
Kanuni Sultan Suleyman Training and Research Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06477653
What this trial is testing

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00036153
What this trial is testing

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 210
Not applicableUnknownNCT06501131
What this trial is testing

A Self-controlled Study of the Effect of Partial Spectral Absence of Visible Light on the Pupil

Who this might be right for
Full Spectrum
Zhongshan Ophthalmic Center, Sun Yat-sen University 66
Large-scale testing (Phase 3)Study completedNCT02151851
What this trial is testing

Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA, Belgium 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation